Pubblicazioni Open Access – Sezione Speciale

5 Dicembre, 2024

PUBBLICAZIONI: 

2021_Triceps Surae Muscle Characteristics in Spastic Hemiparetic Stroke Survivors Treated with Botulinum Toxin Type A. Clinical Implications from Ultrasonographic Evaluation
2022_Reasons and Determinants of BoNT-A Treatment Discontinuation in Patients Living with Spasticity. A 10-Year Retrospective Analysis
2022_The Lack of Systemic and Subclinical Side Effects of Botulinum Neurotoxin Type-A in Patients Affected by Post-Stroke Spasticity. A Longitudinal Cohort Study
2023_Adjunctive treatment and BoNT-A for post-stroke spasticity Are we really focusing on the patient-centered goals
2023_Clinical efficacy of botulinum toxin type A in patients with traumatic brain injury, spinal cord injury, or multiple sclerosis. An observational longitudinal study
2023_Management Of Spastic Equinovarus Foot in Children with Cerebral Palsy
2023_Utilizzo della guida ultrasonografica nell’esecuzione di blocchi diagnostici periferici nel management della spasticità
2024_Assessing muscle architecture with ultrasound
2024_Classification of upper limb spasticity patterns in patients with multiple sclerosis
2024_Do Diagnostic Nerve Blocks Affect the Starting Dose of Botulinum Neurotoxin Type A for Spasticity
2024_Is the silfverskiöld test a valid tool for evaluating calf muscles spastic overactivity in patients with stroke a retrospective observational study
2024_Multiple sclerosis and spasticity the role of anaesthetic nerve blocks on rectus femoris muscle. When should stiff knee be treated with botulinum toxin
2024_Post-stroke spasticity. Follow-up and functional implications of chronic long-term treatment with botulinum toxin
2024_Role of Diagnostic Nerve Blocks in the Goal-Oriented Treatment of Spasticity with Botulinum Toxin Type A